Minocycline hydrochloride and Norfloxacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 7 people who take Minocycline hydrochloride and Norfloxacin. Common interactions include aspartate aminotransferase increased among females, and staphylococcal sepsis among males.

The phase IV clinical study analyzes what interactions people who take Minocycline hydrochloride and Norfloxacin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2023

7 people who take Minocycline hydrochloride and Norfloxacin together, and have interactions are studied.


What is Minocycline hydrochloride?

Minocycline hydrochloride has active ingredients of minocycline hydrochloride. It is used in acne. Currently, eHealthMe is studying from 4,744 Minocycline hydrochloride users.

What is Norfloxacin?

Norfloxacin has active ingredients of norfloxacin. It is used in urinary tract infection. Currently, eHealthMe is studying from 2,342 Norfloxacin users.

Number of Minocycline hydrochloride and Norfloxacin reports submitted per year:

Minocycline hydrochloride and Norfloxacin drug interactions.

Common Minocycline Hydrochloride and Norfloxacin drug interactions by gender *:

female:

  1. Aspartate aminotransferase increased
  2. Beta 2 microglobulin decreased
  3. Beta 2 microglobulin increased
  4. Blood cholesterol increased
  5. Blood lactate dehydrogenase increased
  6. Blood triglycerides increased
  7. Blood uric acid decreased
  8. Convulsions
  9. Depressed level of consciousness
  10. Epistaxis

male:

  1. Staphylococcal sepsis
  2. Acute graft versus host disease in skin
  3. Acute myeloid leukaemia
  4. Epstein-barr virus associated lymphoproliferative disorder
  5. Metastases to lung
  6. Respiratory failure
  7. Post transplant lymphoproliferative disorder


Common Minocycline Hydrochloride and Norfloxacin drug interactions by age *:

0-1:

n/a

2-9:

  1. Acute graft versus host disease
  2. Acute respiratory distress syndrome
  3. Epistaxis
  4. Headache
  5. Hypogammaglobulinaemia
  6. Hypoproteinaemia
  7. Lipids increased
  8. Malaise
  9. Pain
  10. Rash

10-19:

  1. Staphylococcal sepsis
  2. Acute graft versus host disease in skin
  3. Acute myeloid leukaemia
  4. Epstein-barr virus associated lymphoproliferative disorder
  5. Metastases to lung
  6. Respiratory failure
  7. Post transplant lymphoproliferative disorder

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Minocycline hydrochloride and Norfloxacin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Common Minocycline hydrochloride drug interactions:

Browse interactions between Minocycline hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Norfloxacin drug interactions:

Browse interactions between Norfloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on minocycline hydrochloride and norfloxacin (the active ingredients of Minocycline hydrochloride and Norfloxacin, respectively), and Minocycline hydrochloride and Norfloxacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Minocycline hydrochloride and Norfloxacin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: